CJ Bioscience
Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.
311690 | KO
Overview
Corporate Details
- ISIN(s):
- KR7311690002
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 중구 세종대로 14 그랜드센트럴타워 B동 7층, 중구
- Website:
- https://www.cjbioscience.com/en/
Description
CJ Bioscience is a company focused on developing microbiome-based therapeutics to address unmet medical needs. It utilizes a proprietary AI-powered drug discovery platform, Ez-Mx®, to identify and advance novel live biotherapeutic products (LBPs). The company's primary focus is on creating treatments for complex diseases, with a pipeline targeting oncology and inflammatory bowel disease (IBD). Key candidates include CJRB-101, its lead oncology asset, and CJRB-201, a promising oral therapeutic for IBD that has demonstrated significant anti-inflammatory efficacy in preclinical models. In addition to its drug development programs, CJ Bioscience provides next-generation sequencing (NGS) and bioinformatics solutions to the global research community through its EzBioCloud platform.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-08-22 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.5 KB | ||
| 2023-08-18 00:00 |
증권발행결과(자율공시)
|
Korean | 8.3 KB | ||
| 2023-08-18 00:00 |
증권발행실적보고서
|
Korean | 87.5 KB | ||
| 2023-08-14 00:00 |
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
|
Korean | 9.8 KB | ||
| 2023-08-14 00:00 |
반기보고서 (2023.06)
|
Korean | 1.5 MB | ||
| 2023-08-11 00:00 |
유상증자또는주식관련사채등의청약결과(자율공시)
|
Korean | 10.1 KB | ||
| 2023-08-07 00:00 |
유상증자최종발행가액확정
|
Korean | 11.1 KB | ||
| 2023-08-07 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 82.7 KB | ||
| 2023-08-07 00:00 |
특수관계인의유상증자참여
|
Korean | 6.1 KB | ||
| 2023-08-07 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.9 KB | ||
| 2023-08-07 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 35.7 KB | ||
| 2023-08-07 00:00 |
[발행조건확정]증권신고서(지분증권)
|
Korean | 212.2 KB | ||
| 2023-08-07 00:00 |
[기재정정]투자설명서
|
Korean | 2.4 MB | ||
| 2023-07-25 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.7 KB | ||
| 2023-07-25 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.2 KB |
Automate Your Workflow. Get a real-time feed of all CJ Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CJ Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CJ Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
